Back to Type 2 What is Pre

What Is Pre-diabetes?

People with pre-diabetes have blood glucose levels that are higher than normal but not high enough to be diagnosed as diabetes. Pre-diabetes is a warning sign that type 2 diabetes can develop if blood glucose levels aren't reduced over time. Pre-diabetes also raises the risk of developing heart disease, and stroke.

Pre-diabetes is also called impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), depending on the test used to diagnose it. Some people have both IFG and IGT.

Pre-diabetes is far more common in the United States than previously believed. In 2006, about 40% of U.S. adults ages 40 to 74—or 41 million people—had pre-diabetes. About 11% of 12-19 year olds in American (about 2 million teens) have pre-diabetes as measured by impaired fasting glucose. Many people with pre-diabetes go on to develop type 2 diabetes within 10 years.

The good news is that if you have pre-diabetes, you can do a lot to prevent or delay diabetes. Studies clearly show that you can lower your risk of developing diabetes by losing 5 to 7 percent of your body weight through diet and increased physical activity.

«« Back to Type 2 and Double Diabetes
« Prev: How Can You Tell if a Child is at Risk for Type 2? | Next: What are the Signs and Symptoms of Type 2? »

  Back to Type 2 Return to the Top of This Page

Last Updated: Wednesday February 01, 2017 18:57:04
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.